Pneumonia, Bacterial: all 153 studies
Page 1 of 2. Open to participants first (27), then studies with results posted, then the rest; newest registration first within each.
- Cefepime-Zidebactam Versus Ceftazidime-Avibactam With or Without Colistin for Hospital-Acquired or Ventilator-Associated Bacterial PneumoniaNot yet recruitingNCT07885891Phase 3
- Clinical Impact of a Machine Learning Decision Support System for Empirical Antibiotic TherapyNot yet recruitingNCT07762378Not applicable
- ASK0912 Versus Polymyxin B for Injection in Adults With Hospital-Acquired or Ventilator-Associated Bacterial PneumoniaRecruitingNCT07759934Phase 2
- Comparative Study of Adherence to Antibiotic Therapy Among Pediatric Patients: Hospital Emergency Department vs. Primary Care CenterNot yet recruitingNCT07711756
- A Clinical Study of YK-1169 Versus Ceftazidime-Avibactam in Adults With Hospital-Acquired or Ventilator-Associated Bacterial PneumoniaNot yet recruitingNCT07634198Phase 3
- Impact of BioFire FilmArray Pneumonia Panel vs Routine Diagnostics on Antimicrobial Outcomes (DOOR-MAT)RecruitingNCT07585604Not applicable
- Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative BacteriaRecruitingNCT07512596Phase 2
- MP101 in Adults With Acute Pseudomonas Aeruginosa PneumoniaRecruitingNCT07492771Phase 1
- A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Infants Receiving 3-dose Primary Dosing Series Followed by a Booster Dose at 12 to 15 Months of AgeNot yet recruitingNCT07406347Phase 1
- Investigation of the Effects of Oxidized Antigens on the T-Cell Response and the Epigenetic Reprogramming of Neutrophils in Lung Diseases - OXIGENE -Not yet recruitingNCT07386912
- A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABPRecruitingNCT07327619Phase 3
- Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus ComplexRecruitingNCT07326540Phase 3
- Urine Pneumococcal Antigen ProjectRecruitingNCT07181200
- Different Methods of Aerosolized Polymyxin B Inhalation for Treating Carbapenem-Resistant Gram-Negative Bacterial Pneumonia.RecruitingNCT07086391
- A Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Polymyxin B and Colistin Methanesulfonate in Patients With Carbapenem-Resistant Gram-Negative Bacterial InfectionRecruitingNCT06966284
- Novel Tools to Improve Management of Paediatric Community-Acquired Pneumonia - ToolCAPRecruitingNCT06670833Not applicable
- " Study of the Benefit of Nebulized Amikacin in the Treatment of Gram-negative Bacillus Pneumonia Acquired During Mechanical Ventilation in Patients Receiving Extracorporeal Membrane Veno-arterial Oxygenation "RecruitingNCT06602557Phase 2
- Antimicrobial Therapeutic Drug Monitoring During Lung Transplant Perioperative PhaseNot yet recruitingNCT06583642
- FBS-ASaP: Fibrobronchoscopy in ASpiration Pneumonia in the Emergency DepartmentRecruitingNCT06511583
- Diagnostic Accuracy of Pocket-size Lung Ultrasound in Pneumonia Etiology and Complications in Hospitalized ChildrenNot yet recruitingNCT06296693Not applicable
- Eravacycline Combination Therapy for MRABRecruitingNCT06282835
- Rapid De-escalation of Anti-MRSA Therapy Guided by S. Aureus Nares Screening in Case of PneumoniaRecruitingNCT06238297Not applicable
- A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABPRecruitingNCT06162286Phase 3
- A Clinical Trial to Assess the Safety and PK of OMN6 in HABP or VABP Caused by Acinetobacter Baumannii ComplexRecruitingNCT06087536Phase 2
- Study of Leukocyte Immunophenotype and the Lipid Transport System as Predictive Biomarkers of Severe Bacterial InfectionsEnrolling by invitationNCT04178915
- Sphingosine-1-phosphate and PneumoniaRecruitingNCT04007328Phase 2/3
- Fosfomycin I.v. for Treatment of Severely Infected PatientsRecruitingNCT02979951
- A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy InfantsCompletedNCT05412030Phase 2Results posted
- Imipenem/Cilastatin-XNW4107 Versus Imipenem/Cilastatin/Relebactam for Treatment of Participants With Bacterial Pneumonia (XNW4107-302, REITAB-2)CompletedNCT05204563Phase 3Results posted
- Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial PneumoniaCompletedNCT04779242Phase 3Results posted
- Pediatric Helmet CPAP Pilot StudyTerminatedNCT04764929Not applicableResults posted
- PROcalcitonin Impact on Antibiotic Reduction, adverSe Events and AVoidable healthcarE Costs (ProSAVE): A RCTCompletedNCT04158804Not applicableResults posted
- Cefiderocol Concentrations in the Lungs of Hospitalized Patients With Bacterial PneumoniaTerminatedNCT03862040Phase 1Results posted
- A Single Ascending Dose Study in Adults (Stage 1) and Single Ascending Dose-Finding Study (Stage 2) in Elderly Subjects With ASP3772, A Pneumococcal VaccineCompletedNCT03803202Phase 1/2Results posted
- Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016)CompletedNCT03583333Phase 3Results posted
- Efficacy and Safety of Nemonoxacin vs Levofloxacin in Adult Patients With Community-Acquired PneumoniaCompletedNCT03551210Phase 3Results posted
- Vaccination Education Through Pharmacists and Senior Centers (VEPSC)CompletedNCT03239665Not applicableResults posted
- Cx611-0204 SEPCELL StudyCompletedNCT03158727Phase 1/2Results posted
- Urease Breath Test for Rapid Characterization of PneumoniaCompletedNCT03100760Results posted
- Phase II Study of Oral Nafithromycin in CABPCompletedNCT02903836Phase 2Results posted
- Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13)CompletedNCT02531438Phase 3Results posted
- Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014)CompletedNCT02493764Phase 3Results posted
- Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative PneumoniaCompletedNCT01969799Phase 2Results posted
- Inhaled Amikacin Solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative PneumoniaCompletedNCT01799993Phase 3Results posted
- Clinical Trials to Reduce the Risk of Antimicrobial ResistanceTerminatedNCT01570192Phase 2Results posted
- Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial PneumoniaCompletedNCT01524302Phase 4Results posted
- A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in AsiaCompletedNCT01371838Phase 3Results posted
- Rapid Empiric Treatment With Oseltamivir Study (RETOS)CompletedNCT01248715Phase 4Results posted
- The Study of Unasyn-S 12g/Day for Community Acquired Pneumonia (CAP)CompletedNCT01189487Phase 3Results posted
- A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial PneumoniaTerminatedNCT01110421Phase 3Results posted
- A Study Of Intravenous Sulopenem And Oral PF-03709270 In Community Acquired Pneumonia That Requires HospitalizationCompletedNCT00797108Phase 2Results posted
- Study Evaluating Safety and Efficacy of Tigecycline Versus Imipenem/Cilastatin Subjects With Hospital-Acquired PneumoniaTerminatedNCT00707239Phase 2Results posted
- Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired PneumoniaCompletedNCT00621504Phase 3Results posted
- A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or PneumoniaCompletedNCT00515034Phase 2Results posted
- Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired PneumoniaCompletedNCT00509106Phase 3Results posted
- An Effectiveness, Safety, and Microbiology Study of Doripenem in Patients With Nosocomial (Hospital-acquired) PneumoniaCompletedNCT00502801Phase 2Results posted
- Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of AgeCompletedNCT00488345Phase 2Results posted
- Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus AureusCompletedNCT00124020Phase 3Results posted
- Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus AureusCompletedNCT00107952Phase 3Results posted
- Combination vs. Monotherapy for Stenotrophomonas Maltophilia InfectionsCompletedNCT07593547
- Artificial Intelligence-Based Evaluation of Chest X-Rays in Ventilator-Associated PneumoniaCompletedNCT07509697
- Trial to Evaluate Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults Aged 50 To 64 YearsActive, not recruitingNCT07428759Phase 1
- Derivation and Validation of the Risk Evaluation Score for Pneumonia Involving Resistant Entities (RESPIRE)CompletedNCT07425561
- A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Toddlers 12 to 15 Months of Age Receiving a Single Booster DoseActive, not recruitingNCT07406334Phase 1
- Breathing Pattern Description in Pneumonia PatientsActive, not recruitingNCT07286552
- A Trial to Evaluate the Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults 50 To 64 Years of AgeCompletedNCT07105722Phase 1
- Comparison Between the Progostic Value of the Procalcitonin and the Platelet/Total Leukocytic Count Ratio in SepsisCompletedNCT06991686
- A Trial of HRS-8427 in the Treatment of Adults With Bacterial PneumoniaCompletedNCT06841731Phase 2
- Efficacy and Safety of Faropenem in Bangladeshi Adult Patients With Community-Acquired Bacterial Pneumonia (CABP)CompletedNCT06804096Phase 4
- A Study to Evaluate Tolerability, Safety and Immunogenicity of MVX01 Pneumococcal VaccineActive, not recruitingNCT06337643Phase 1
- Application of the Recommendations of the SPLIF (French Society of Infectious Pathology) in a Geriatric Population on the Duration of Treatment for Bacterial PneumoniaCompletedNCT06307730
- MASTERMIND-Pneumonia Study (Also Known as Pneumonia Direct Pilot)CompletedNCT06181669
- Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABPWithdrawnNCT06168734Phase 3
- CPAP Therapy Through a Helmet or a Full Face Mask in Patients With Acute Hypoxemic Respiratory Failure: Cross-over StudyCompletedNCT06113432Not applicable
- Using Probability of Community-Acquired Pneumonia to Tailor Antimicrobials Among InpatientsCompletedNCT05976581Not applicable
- P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant EnterobacteralesCompletedNCT05905055Phase 3
- Discharge Stewardship in Children's HospitalsCompletedNCT05826873Not applicable
- Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial PneumoniaActive, not recruitingNCT05776004Phase 2
- A 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CMTX-101TerminatedNCT05629741Phase 1
- Imipenem/Cilastatin/Relebactam Pharmacokinetics, Safety, and Outcomes in Adults and Adolescents With Cystic FibrosisTerminatedNCT05561764Phase 4
- Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 PneumoniaTerminatedNCT05531149Phase 3
- Avoidable Hospitalizations/ Emergency Department Visits- Systematic Review and Meta-synthesis of Qualitative ResearchStatus unknownNCT05456906
- Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 PatientsCompletedNCT05417997Phase 3
- Effectiveness of Oral Management Strategies on Improving Oral Frailty and Oral BacteriaCompletedNCT05407532Not applicable
- Cefiderocol Pharmacokinetics in Adult Patients With Cystic FibrosisCompletedNCT05314764Phase 4
- Impact of Pharmacist-led Educational Intervention on Pneumococcal Vaccination Rates in Cancer PatientsCompletedNCT05229081Not applicable
- Prevalence and Serotype of Streptococcus Pneumoniae Hospitalized Adult With Community-Acquired PneumoniaCompletedNCT05173727
- Influence of Pneumonia on Delayed Cerebral Ischemia After Subarachnoid Hemorrhage . SAH-CIP (SubArrachnoid Hemorrhage - Cerebral Infarction Pneumonia)CompletedNCT05094349
- Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)Status unknownNCT04952337
- Diagnostic Accuracy of Infection Biomarkers in the Initial Investigation of Patients With Suspected PneumoniaCompletedNCT04652167
- The Effect of a Point-of-care Sputum Specimen Assay at the Emergency Department for Patients Suspected of PneumoniaCompletedNCT04651712Not applicable
- Aerosolized Colistin to Mechanical Ventilated Patients With PneumoniaCompletedNCT04633317Not applicable
- Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER CancerCompletedNCT04540081Not applicable
- Determinants of COVID-19 Pneumonia (MC-19)CompletedNCT04387799
- Development of Risk Score Model and Decision Tree Algorithm for Predicting Infections With CRKp in Colonized PatientsStatus unknownNCT04229511
- Oropharyngeal Aspiration to Reduce Ventilator-Related PneumoniaCompletedNCT04107363Not applicable
- Shortened Antibiotic Treatment of 5 Days in Community-Acquired PneumoniaCompletedNCT04089787Phase 4
- Pneumonia in the ImmunoCompromised - Use of the Karius Test for the Detection of Undiagnosed PathogensCompletedNCT04047719
- Diagnostic and Prognostic Biomarkers for Childhood Bacterial PneumoniaCompletedNCT03996967
- Relation Between the Volume of Subglottic Secretion and Risk of Extubation Failure in ICU Patients (SEGEX)Status unknownNCT03946371